Hongbin Yu

State Key Laboratory Of Biotherapy
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Dual-targeting LILRB3/LILRB4 CAR-T cells for the treatment of monocytic acute myeloid leukemia.

Dual-targeting LILRB3/LILRB4 CAR-T cells for the treatment of monocytic acute myeloid leukemia.

Journal: Biochemical pharmacology

Published: March 10, 2026

Hydrophilic-Stable Nucleoside-Based Hydrogen-Bonded Organic Frameworks (N-HOF) for Therapeutic Bacterial Hybrid Systems.

Hydrophilic-Stable Nucleoside-Based Hydrogen-Bonded Organic Frameworks (N-HOF) for Therapeutic Bacterial Hybrid Systems.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: February 28, 2026

System-level metabolic and enzyme engineering enables high-titer gastrodin biosynthesis in yeast.

System-level metabolic and enzyme engineering enables high-titer gastrodin biosynthesis in yeast.

Journal: Bioresource technology

Published: February 28, 2026

Recent advances in CRISPR-Cas system for Saccharomyces cerevisiae engineering.

Recent advances in CRISPR-Cas system for Saccharomyces cerevisiae engineering.

Journal: Biotechnology advances

Published: December 04, 2024

Effectiveness of nirmatrelvir/ritonavir in hospitalized haematological malignancy patients with mild-to-moderate COVID-19: A retrospective study.

Effectiveness of nirmatrelvir/ritonavir in hospitalized haematological malignancy patients with mild-to-moderate COVID-19: A retrospective study.

Journal: British journal of haematology

Published: November 10, 2024

Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis.

Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis.

Journal: Journal of cancer research and clinical oncology

Published: January 06, 2024

Changes in the clinical features, treatments, and outcomes of patients with systemic light chain (AL) amyloidosis in Western China, 2010-2022: A multicenter, retrospective, real-world study.

Changes in the clinical features, treatments, and outcomes of patients with systemic light chain (AL) amyloidosis in Western China, 2010-2022: A multicenter, retrospective, real-world study.

Journal: Chinese medical journal

Published: December 07, 2023

Anaerobic purinolytic enzymes enable dietary purine clearance by engineered gut bacteria.

Anaerobic purinolytic enzymes enable dietary purine clearance by engineered gut bacteria.

Journal: Cell chemical biology

Published: January 06, 2023

FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma.

FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma.

Journal: Journal of hematology & oncology

Published: October 24, 2022

Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review.

Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review.

Journal: Frontiers in oncology

Published: April 06, 2022

The prognostic significance of single-nucleotide polymorphism array-based whole-genome analysis and uniparental disomy in myelodysplastic syndrome.

The prognostic significance of single-nucleotide polymorphism array-based whole-genome analysis and uniparental disomy in myelodysplastic syndrome.

Journal: International journal of laboratory hematology

Published: October 09, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026